Form 4 for ANTX AN2 Therapeutics, Inc.
Accepted 2026-08-14 14:12:12 ET · period of report 2026-08-14 · accession 0001193125-26-351801 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-08-14 14:12 | 2026-08-14 | ANTX | Zakrzewski Joseph S | Dir | G - Gift | $0.00 | -405.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-14 | G | D | 405,880 | $0.00 | 0 | I See footnote | — | — | (F1) Reflects a gift of shares to the children of the Reporting Person. (F2) The shares are held by Nancy Zakrzewski TTEE Z3 Trust U/A DTD 11/25/14 ("Z3 Trust"). The Reporting Person disavows beneficial ownership of the shares held by Z3 Trust. |